日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI

基于深度学习的多参数磁共振成像技术在4级胶质瘤靶区勾画和疗效评估中的肿瘤分割可行性研究

期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdad037
Hannisdal, Marianne H; Goplen, Dorota; Alam, Saruar; Haasz, Judit; Oltedal, Leif; Rahman, Mohummad A; Rygh, Cecilie Brekke; Lie, Stein Atle; Lundervold, Arvid; Chekenya, Martha
胶质瘤
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions

两家独立机构对连续467例胶质母细胞瘤患者的生存情况进行分析：与预后因素和复发治疗的关系

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0281166
Blakstad, Hanne; Brekke, Jorunn; Rahman, Mohummad Aminur; Arnesen, Victoria Smith; Miletic, Hrvoje; Brandal, Petter; Lie, Stein Atle; Chekenya, Martha; Goplen, Dorota
细胞生物学
发表日期：2023
文献求助 收藏

Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway

硼替佐米通过 ATG5 依赖性途径消除替莫唑胺诱导的自噬通量

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.6
doi:10.3389/fcell.2022.1022191
Mohummad Aminur Rahman, Agnete S T Engelsen, Shahin Sarowar, Christian Bindesbøll, Even Birkeland, Dorota Goplen, Maria L Lotsberg, Stian Knappskog, Anne Simonsen, Martha Chekenya
信号转导
细胞生物学
Autophagy
发表日期：2022
文献求助 收藏

P14.09 BORTEM-17: A Phase IB/II Single-Arm, Control Non-Randomized, Multicentre, Open Label Clinical Trial for Recurrent Glioblastoma with unmethylated MGMT promoter (NCT03643549)

P14.09 BORTEM-17：一项针对 MGMT 启动子未甲基化的复发性胶质母细胞瘤的 IB/II 期单臂、对照、非随机、多中心、开放标签临床试验 (NCT03643549)

期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noaa224
Lupo, Janine M; Goplen, D; Rahman, M A; Arnesen, V S; Brekke, J; Simonsen, A; Andreas, W; Marienhagen, K; Oltedal, L; Haasz, J; Miletic, H; Solheim, T S; Brandal, P; Lie, S A; Chekenya, M
细胞生物学
表观遗传
MGMT
发表日期：2021
文献求助 收藏

Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy

胶质母细胞瘤免疫治疗中设计型T细胞和NK细胞的挑战与前景

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13194986
Arnesen, Victoria Smith; Gras Navarro, Andrea; Chekenya, Martha
细胞生物学
T细胞
T细胞
免疫/内分泌
发表日期：2021
文献求助 收藏

Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study

序贯使用硼替佐米和替莫唑胺治疗可促进胶质母细胞瘤患者的免疫反应，并取得良好的临床疗效：一项 1B 期研究

期刊:Immunity Inflammation and Disease
影响因子:2.7
doi:10.1002/iid3.315
Rahman, Mohummad A; Brekke, Jorunn; Arnesen, Victoria; Hannisdal, Marianne H; Navarro, Andrea G; Waha, Andreas; Herfindal, Lars; Rygh, Cecilie B; Bratland, Eirik; Brandal, Petter; Haasz, Judit; Oltedal, Leif; Miletic, Hrvoje; Lundervold, Arvid; Lie, Stein A; Goplen, Dorota; Chekenya, Martha
细胞生物学
免疫/内分泌
发表日期：2020
文献求助 收藏

Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival

在替莫唑胺之前给予硼替佐米会消耗 MGMT，使未甲基化 MGMT 启动子的胶质母细胞瘤具有化学敏感性，并延长动物存活期

期刊:British Journal of Cancer
影响因子:6.4
doi:10.1038/s41416-019-0551-1
Mohummad Aminur Rahman, Andrea Gras Navarro, Jorunn Brekke, Agnete Engelsen, Christian Bindesbøll, Shahin Sarowar, Marzieh Bahador, Ersilia Bifulco, Dorota Goplen, Andreas Waha, Stein Atle Lie, Bjørn Tore Gjertsen, Frode Selheim, Per Øyvind Enger, Anne Simonsen, Martha Chekenya
细胞生物学
肿瘤
胶质瘤
其它细胞
发表日期：2019
文献求助 收藏

Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival

用硼替佐米预处理胶质母细胞瘤可通过 TRAIL/DR5 介导的细胞凋亡增强自然杀伤细胞的细胞毒性并延长动物存活期

期刊:Cancers
影响因子:
doi:10.3390/cancers11070996
Andrea Gras Navarro, Heidi Espedal, Justin Vareecal Joseph, Laura Trachsel-Moncho, Marzieh Bahador, Bjørn Tore Gjertsen, Einar Klæboe Kristoffersen, Anne Simonsen, Hrvoje Miletic, Per Øyvind Enger, Mohummad Aminur Rahman, Martha Chekenya
免疫
细胞生物学
自然杀伤细胞
Apoptosis
AROS
发表日期：2019
文献求助 收藏

Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients

肿瘤中（而非外周血中）浸润增加和耐受抗原特异性 CD8+ TEM 细胞对 HCMV+ 胶质母细胞瘤患者的生存没有影响

期刊:Oncoimmunology
影响因子:
doi:10.1080/2162402X.2017.1336272
M Bahador, A Gras Navarro, M A Rahman, M Dominguez-Valentin, S Sarowar, E Ulvestad, G Njølstad, S A Lie, E K Kristoffersen, E Bratland, M Chekenya
肿瘤
胶质瘤
T细胞
IF
IHC-P
WB
Human
发表日期：2017
文献求助 收藏

Therapeutic potential and challenges of natural killer cells in treatment of solid tumors

自然杀伤细胞在实体瘤治疗中的治疗潜力和挑战

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2015.00202
Gras Navarro, Andrea; Björklund, Andreas T; Chekenya, Martha
自然杀伤细胞
细胞生物学
发表日期：2015
文献求助 收藏